Early cardiac toxicity of 4′-iodo-4′-deoxydoxorubicin
- 31 December 1991
- journal article
- Published by Elsevier BV in European Journal of Cancer and Clinical Oncology
- Vol. 27 (12), 1601-1604
- https://doi.org/10.1016/0277-5379(91)90423-b
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Pharmacology and Clinical Toxicity of 4'-Iodo-4'-deoxydoxorubicin: An Example of Successful Application of Pharmacokinetics to Dose Escalation in Phase I TrialsJNCI Journal of the National Cancer Institute, 1990
- The Rat Model in the Comparative Evaluation of Anthracyclines CardiotoxicityTumori Journal, 1989
- Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.Heart, 1988
- Evaluation of cardiotoxicity of a new anthracycline derivative: 4? -deoxy-4? -iodo-doxorubicinInvestigational New Drugs, 1988
- Acute arrhythmogenicity of doxorubicin administrationCancer, 1987
- Assessment of Left Ventricular Contractility in Patients Receiving DoxorubicinAnnals of Internal Medicine, 1983
- Role of the fast-exchanging calcium compartment in the early cardiotoxicity of anthracycline analogsBiochemical Pharmacology, 1983
- Evaluation of early doxorubicin-induced cardiotoxicity by means of systolic time intervalsCancer Chemotherapy and Pharmacology, 1979
- Early anthracycline cardiotoxicityThe American Journal of Medicine, 1978
- Combined hemodynamic-ultrasonic method for studying left ventricular wall stress: Comparison with angiographyThe American Journal of Cardiology, 1976